Recap: Oncternal Therapeutics Q4 Earnings

Oncternal Therapeutics ONCT reported its Q4 earnings results on Thursday, March 7, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.

Oncternal Therapeutics missed estimated earnings by -1.0%, reporting an EPS of $-3.11 versus an estimate of $-3.07.

Revenue was up $126 thousand from the same period last year.

Last quarter the company missed on EPS by $0.6 which was followed by a 3.0% drop in the share price the next day.

Here's a look at Oncternal Therapeutics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-2.8	-3.2	-4	-4.2
EPS Actual	-3.4	-3	-4	-4
Revenue Estimate	120K	200K	170K	330K
Revenue Actual	179K	106K	203K	171K

To track all earnings releases for Oncternal Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar